Japan Drug Repurposing Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major Region

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Drug Repurposing market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Drug Repurposing market. Detailed analysis of key players, along with key growth strategies adopted by Drug Repurposing industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.


    By Player:

    • Sandoz

    • Hoffmann-La Roche

    • Teva Pharmaceuticals

    • Abbott Healthcare

    • Johnson & Johnson

    • NuMedii.

    • Pfizer AG

    • AbbVie Inc.


    By Type:

    • Orally Drug

    • Intravenously Drug


    By End-User:

    • Central Nervous Disorders

    • Cardiovascular Disorders

    • Oncology

    • Metabolic

    • Autoimmune

    • Other


    By Region:

    • Hokkaido

    • Tohoku

    • Kanto

    • Chubu

    • Kinki

    • Chugoku

    • Shikoku

    • Kyushu

  • 1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Drug Repurposing Market

    • 1.3 Market Segment by Type

      • 1.3.1 Japan Drug Repurposing Market Size and Growth Rate of Orally Drug from 2014 to 2026

      • 1.3.2 Japan Drug Repurposing Market Size and Growth Rate of Intravenously Drug from 2014 to 2026

    • 1.4 Market Segment by Application

      • 1.4.1 Japan Drug Repurposing Market Size and Growth Rate of Central Nervous Disorders from 2014 to 2026

      • 1.4.2 Japan Drug Repurposing Market Size and Growth Rate of Cardiovascular Disorders from 2014 to 2026

      • 1.4.3 Japan Drug Repurposing Market Size and Growth Rate of Oncology from 2014 to 2026

      • 1.4.4 Japan Drug Repurposing Market Size and Growth Rate of Metabolic from 2014 to 2026

      • 1.4.5 Japan Drug Repurposing Market Size and Growth Rate of Autoimmune from 2014 to 2026

      • 1.4.6 Japan Drug Repurposing Market Size and Growth Rate of Other from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Hokkaido Drug Repurposing Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Tohoku Drug Repurposing Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Kanto Drug Repurposing Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Chubu Drug Repurposing Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Kinki Drug Repurposing Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Chugoku Drug Repurposing Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Shikoku Drug Repurposing Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Kyushu Drug Repurposing Consumption Market Size and Growth Rate from 2014 to 2026


    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants


    3 Segmentation of Drug Repurposing Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Drug Repurposing by Major Types

      • 3.4.1 Market Size and Growth Rate of Orally Drug

      • 3.4.2 Market Size and Growth Rate of Intravenously Drug


    4 Segmentation of Drug Repurposing Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Drug Repurposing by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Drug Repurposing in Central Nervous Disorders

      • 4.4.2 Market Size and Growth Rate of Drug Repurposing in Cardiovascular Disorders

      • 4.4.3 Market Size and Growth Rate of Drug Repurposing in Oncology

      • 4.4.4 Market Size and Growth Rate of Drug Repurposing in Metabolic

      • 4.4.5 Market Size and Growth Rate of Drug Repurposing in Autoimmune

      • 4.4.6 Market Size and Growth Rate of Drug Repurposing in Other


    5 Market Analysis by Regions

    • 5.1 Japan Drug Repurposing Production Analysis by Regions

    • 5.2 Japan Drug Repurposing Consumption Analysis by Regions


    6 Hokkaido Drug Repurposing Landscape Analysis

    • 6.1 Hokkaido Drug Repurposing Landscape Analysis by Major Types

    • 6.2 Hokkaido Drug Repurposing Landscape Analysis by Major End-Users


    7 Tohoku Drug Repurposing Landscape Analysis

    • 7.1 Tohoku Drug Repurposing Landscape Analysis by Major Types

    • 7.2 Tohoku Drug Repurposing Landscape Analysis by Major End-Users


    8 Kanto Drug Repurposing Landscape Analysis

    • 8.1 Kanto Drug Repurposing Landscape Analysis by Major Types

    • 8.2 Kanto Drug Repurposing Landscape Analysis by Major End-Users


    9 Chubu Drug Repurposing Landscape Analysis

    • 9.1 Chubu Drug Repurposing Landscape Analysis by Major Types

    • 9.2 Chubu Drug Repurposing Landscape Analysis by Major End-Users


    10 Kinki Drug Repurposing Landscape Analysis

    • 10.1 Kinki Drug Repurposing Landscape Analysis by Major Types

    • 10.2 Kinki Drug Repurposing Landscape Analysis by Major End-Users


    11 Chugoku Drug Repurposing Landscape Analysis

    • 11.1 Chugoku Drug Repurposing Landscape Analysis by Major Types

    • 11.2 Chugoku Drug Repurposing Landscape Analysis by Major End-Users


    12 Shikoku Drug Repurposing Landscape Analysis

    • 12.1 Shikoku Drug Repurposing Landscape Analysis by Major Types

    • 12.2 Shikoku Drug Repurposing Landscape Analysis by Major End-Users


    13 Kyushu Drug Repurposing Landscape Analysis

    • 13.1 Kyushu Drug Repurposing Landscape Analysis by Major Types

    • 13.2 Kyushu Drug Repurposing Landscape Analysis by Major End-Users


    14 Major Players Profiles

    • 14.1 Sandoz

      • 14.1.1 Sandoz Company Profile and Recent Development

      • 14.1.2 Market Performance

      • 14.1.3 Product and Service Introduction

    • 14.2 Hoffmann-La Roche

      • 14.2.1 Hoffmann-La Roche Company Profile and Recent Development

      • 14.2.2 Market Performance

      • 14.2.3 Product and Service Introduction

    • 14.3 Teva Pharmaceuticals

      • 14.3.1 Teva Pharmaceuticals Company Profile and Recent Development

      • 14.3.2 Market Performance

      • 14.3.3 Product and Service Introduction

    • 14.4 Abbott Healthcare

      • 14.4.1 Abbott Healthcare Company Profile and Recent Development

      • 14.4.2 Market Performance

      • 14.4.3 Product and Service Introduction

    • 14.5 Johnson & Johnson

      • 14.5.1 Johnson & Johnson Company Profile and Recent Development

      • 14.5.2 Market Performance

      • 14.5.3 Product and Service Introduction

    • 14.6 NuMedii.

      • 14.6.1 NuMedii. Company Profile and Recent Development

      • 14.6.2 Market Performance

      • 14.6.3 Product and Service Introduction

    • 14.7 Pfizer AG

      • 14.7.1 Pfizer AG Company Profile and Recent Development

      • 14.7.2 Market Performance

      • 14.7.3 Product and Service Introduction

    • 14.8 AbbVie Inc.

      • 14.8.1 AbbVie Inc. Company Profile and Recent Development

      • 14.8.2 Market Performance

      • 14.8.3 Product and Service Introduction

     

    The List of Tables and Figures (Totals 151 Figures and 146 Tables)

     

    • Figure Japan Drug Repurposing Market Size and Growth Rate of Orally Drug from 2014 to 2026

    • Figure Japan Drug Repurposing Market Size and Growth Rate of Intravenously Drug from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Japan Drug Repurposing Market Size and Growth Rate of Central Nervous Disorders from 2014 to 2026

    • Figure Japan Drug Repurposing Market Size and Growth Rate of Cardiovascular Disorders from 2014 to 2026

    • Figure Japan Drug Repurposing Market Size and Growth Rate of Oncology from 2014 to 2026

    • Figure Japan Drug Repurposing Market Size and Growth Rate of Metabolic from 2014 to 2026

    • Figure Japan Drug Repurposing Market Size and Growth Rate of Autoimmune from 2014 to 2026

    • Figure Japan Drug Repurposing Market Size and Growth Rate of Other from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure Hokkaido Drug Repurposing Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Tohoku Drug Repurposing Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kanto Drug Repurposing Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chubu Drug Repurposing Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kinki Drug Repurposing Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chugoku Drug Repurposing Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Shikoku Drug Repurposing Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kyushu Drug Repurposing Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Drug Repurposing Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Drug Repurposing

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Drug Repurposing by Different Types from 2014 to 2026

    • Table Consumption Share of Drug Repurposing by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Orally Drug

    • Figure Market Size and Growth Rate of Intravenously Drug

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Drug Repurposing by Different End-Users from 2014 to 2026

    • Table Consumption Share of Drug Repurposing by Different End-Users from 2014 to 2026

    • Figure Japan Drug Repurposing Market Size and Growth Rate of Central Nervous Disorders from 2014 to 2026

    • Figure Japan Drug Repurposing Market Size and Growth Rate of Cardiovascular Disorders from 2014 to 2026

    • Figure Japan Drug Repurposing Market Size and Growth Rate of Oncology from 2014 to 2026

    • Figure Japan Drug Repurposing Market Size and Growth Rate of Metabolic from 2014 to 2026

    • Figure Japan Drug Repurposing Market Size and Growth Rate of Autoimmune from 2014 to 2026

    • Figure Japan Drug Repurposing Market Size and Growth Rate of Other from 2014 to 2026

    • Table Japan Drug Repurposing Production by Regions

    • Table Japan Drug Repurposing Production Share by Regions

    • Figure Japan Drug Repurposing Production Share by Regions in 2014

    • Figure Japan Drug Repurposing Production Share by Regions in 2018

    • Figure Japan Drug Repurposing Production Share by Regions in 2026

    • Table Japan Drug Repurposing Consumption by Regions

    • Table Japan Drug Repurposing Consumption Share by Regions

    • Figure Japan Drug Repurposing Consumption Share by Regions in 2014

    • Figure Japan Drug Repurposing Consumption Share by Regions in 2018

    • Figure Japan Drug Repurposing Consumption Share by Regions in 2026

    • Table Hokkaido Drug Repurposing Consumption by Types from 2014 to 2026

    • Table Hokkaido Drug Repurposing Consumption Share by Types from 2014 to 2026

    • Figure Hokkaido Drug Repurposing Consumption Share by Types in 2014

    • Figure Hokkaido Drug Repurposing Consumption Share by Types in 2018

    • Figure Hokkaido Drug Repurposing Consumption Share by Types in 2026

    • Table Hokkaido Drug Repurposing Consumption by End-Users from 2014 to 2026

    • Table Hokkaido Drug Repurposing Consumption Share by End-Users from 2014 to 2026

    • Figure Hokkaido Drug Repurposing Consumption Share by End-Users in 2014

    • Figure Hokkaido Drug Repurposing Consumption Share by End-Users in 2018

    • Figure Hokkaido Drug Repurposing Consumption Share by End-Users in 2026

    • Table Tohoku Drug Repurposing Consumption by Types from 2014 to 2026

    • Table Tohoku Drug Repurposing Consumption Share by Types from 2014 to 2026

    • Figure Tohoku Drug Repurposing Consumption Share by Types in 2014

    • Figure Tohoku Drug Repurposing Consumption Share by Types in 2018

    • Figure Tohoku Drug Repurposing Consumption Share by Types in 2026

    • Table Tohoku Drug Repurposing Consumption by End-Users from 2014 to 2026

    • Table Tohoku Drug Repurposing Consumption Share by End-Users from 2014 to 2026

    • Figure Tohoku Drug Repurposing Consumption Share by End-Users in 2014

    • Figure Tohoku Drug Repurposing Consumption Share by End-Users in 2018

    • Figure Tohoku Drug Repurposing Consumption Share by End-Users in 2026

    • Table Kanto Drug Repurposing Consumption by Types from 2014 to 2026

    • Table Kanto Drug Repurposing Consumption Share by Types from 2014 to 2026

    • Figure Kanto Drug Repurposing Consumption Share by Types in 2014

    • Figure Kanto Drug Repurposing Consumption Share by Types in 2018

    • Figure Kanto Drug Repurposing Consumption Share by Types in 2026

    • Table Kanto Drug Repurposing Consumption by End-Users from 2014 to 2026

    • Table Kanto Drug Repurposing Consumption Share by End-Users from 2014 to 2026

    • Figure Kanto Drug Repurposing Consumption Share by End-Users in 2014

    • Figure Kanto Drug Repurposing Consumption Share by End-Users in 2018

    • Figure Kanto Drug Repurposing Consumption Share by End-Users in 2026

    • Table Chubu Drug Repurposing Consumption by Types from 2014 to 2026

    • Table Chubu Drug Repurposing Consumption Share by Types from 2014 to 2026

    • Figure Chubu Drug Repurposing Consumption Share by Types in 2014

    • Figure Chubu Drug Repurposing Consumption Share by Types in 2018

    • Figure Chubu Drug Repurposing Consumption Share by Types in 2026

    • Table Chubu Drug Repurposing Consumption by End-Users from 2014 to 2026

    • Table Chubu Drug Repurposing Consumption Share by End-Users from 2014 to 2026

    • Figure Chubu Drug Repurposing Consumption Share by End-Users in 2014

    • Figure Chubu Drug Repurposing Consumption Share by End-Users in 2018

    • Figure Chubu Drug Repurposing Consumption Share by End-Users in 2026

    • Table Kinki Drug Repurposing Consumption by Types from 2014 to 2026

    • Table Kinki Drug Repurposing Consumption Share by Types from 2014 to 2026

    • Figure Kinki Drug Repurposing Consumption Share by Types in 2014

    • Figure Kinki Drug Repurposing Consumption Share by Types in 2018

    • Figure Kinki Drug Repurposing Consumption Share by Types in 2026

    • Table Kinki Drug Repurposing Consumption by End-Users from 2014 to 2026

    • Table Kinki Drug Repurposing Consumption Share by End-Users from 2014 to 2026

    • Figure Kinki Drug Repurposing Consumption Share by End-Users in 2014

    • Figure Kinki Drug Repurposing Consumption Share by End-Users in 2018

    • Figure Kinki Drug Repurposing Consumption Share by End-Users in 2026

    • Table Chugoku Drug Repurposing Consumption by Types from 2014 to 2026

    • Table Chugoku Drug Repurposing Consumption Share by Types from 2014 to 2026

    • Figure Chugoku Drug Repurposing Consumption Share by Types in 2014

    • Figure Chugoku Drug Repurposing Consumption Share by Types in 2018

    • Figure Chugoku Drug Repurposing Consumption Share by Types in 2026

    • Table Chugoku Drug Repurposing Consumption by End-Users from 2014 to 2026

    • Table Chugoku Drug Repurposing Consumption Share by End-Users from 2014 to 2026

    • Figure Chugoku Drug Repurposing Consumption Share by End-Users in 2014

    • Figure Chugoku Drug Repurposing Consumption Share by End-Users in 2018

    • Figure Chugoku Drug Repurposing Consumption Share by End-Users in 2026

    • Table Shikoku Drug Repurposing Consumption by Types from 2014 to 2026

    • Table Shikoku Drug Repurposing Consumption Share by Types from 2014 to 2026

    • Figure Shikoku Drug Repurposing Consumption Share by Types in 2014

    • Figure Shikoku Drug Repurposing Consumption Share by Types in 2018

    • Figure Shikoku Drug Repurposing Consumption Share by Types in 2026

    • Table Shikoku Drug Repurposing Consumption by End-Users from 2014 to 2026

    • Table Shikoku Drug Repurposing Consumption Share by End-Users from 2014 to 2026

    • Figure Shikoku Drug Repurposing Consumption Share by End-Users in 2014

    • Figure Shikoku Drug Repurposing Consumption Share by End-Users in 2018

    • Figure Shikoku Drug Repurposing Consumption Share by End-Users in 2026

    • Table Kyushu Drug Repurposing Consumption by Types from 2014 to 2026

    • Table Kyushu Drug Repurposing Consumption Share by Types from 2014 to 2026

    • Figure Kyushu Drug Repurposing Consumption Share by Types in 2014

    • Figure Kyushu Drug Repurposing Consumption Share by Types in 2018

    • Figure Kyushu Drug Repurposing Consumption Share by Types in 2026

    • Table Kyushu Drug Repurposing Consumption by End-Users from 2014 to 2026

    • Table Kyushu Drug Repurposing Consumption Share by End-Users from 2014 to 2026

    • Figure Kyushu Drug Repurposing Consumption Share by End-Users in 2014

    • Figure Kyushu Drug Repurposing Consumption Share by End-Users in 2018

    • Figure Kyushu Drug Repurposing Consumption Share by End-Users in 2026

    • Table Company Profile and Development Status of Sandoz

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sandoz

    • Figure Sales and Growth Rate Analysis of Sandoz

    • Figure Revenue and Market Share Analysis of Sandoz

    • Table Product and Service Introduction of Sandoz

    • Table Company Profile and Development Status of Hoffmann-La Roche

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hoffmann-La Roche

    • Figure Sales and Growth Rate Analysis of Hoffmann-La Roche

    • Figure Revenue and Market Share Analysis of Hoffmann-La Roche

    • Table Product and Service Introduction of Hoffmann-La Roche

    • Table Company Profile and Development Status of Teva Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Teva Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Teva Pharmaceuticals

    • Table Product and Service Introduction of Teva Pharmaceuticals

    • Table Company Profile and Development Status of Abbott Healthcare

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott Healthcare

    • Figure Sales and Growth Rate Analysis of Abbott Healthcare

    • Figure Revenue and Market Share Analysis of Abbott Healthcare

    • Table Product and Service Introduction of Abbott Healthcare

    • Table Company Profile and Development Status of Johnson & Johnson

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson

    • Figure Sales and Growth Rate Analysis of Johnson & Johnson

    • Figure Revenue and Market Share Analysis of Johnson & Johnson

    • Table Product and Service Introduction of Johnson & Johnson

    • Table Company Profile and Development Status of NuMedii.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of NuMedii.

    • Figure Sales and Growth Rate Analysis of NuMedii.

    • Figure Revenue and Market Share Analysis of NuMedii.

    • Table Product and Service Introduction of NuMedii.

    • Table Company Profile and Development Status of Pfizer AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer AG

    • Figure Sales and Growth Rate Analysis of Pfizer AG

    • Figure Revenue and Market Share Analysis of Pfizer AG

    • Table Product and Service Introduction of Pfizer AG

    • Table Company Profile and Development Status of AbbVie Inc.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AbbVie Inc.

    • Figure Sales and Growth Rate Analysis of AbbVie Inc.

    • Figure Revenue and Market Share Analysis of AbbVie Inc.

    • Table Product and Service Introduction of AbbVie Inc.

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.